Galvanize Therapeutics
Galvanize Therapeutics is a medical technology company specializing in energy-based devices aimed at improving biological processes for therapeutic applications. Founded in 2022 by Apple Tree Partners, the company focuses on developing innovative solutions to treat various medical conditions, including chronic bronchitis, cardiac arrhythmias, and solid tumors. Its platform employs short-duration, high-voltage electrical pulses to create electric fields that destabilize cells through multiple biochemical mechanisms. This technology enhances the ability of medical professionals to provide effective healthcare services, positioning Galvanize Therapeutics as a potential leader in delivering cutting-edge medical innovations.
Galaxy Medical
Acquisition in 2022
Galaxy Medical is a privately held medical device company focused on developing advanced technologies for the treatment of cardiac arrhythmia. The company specializes in a device that employs pulsed electric field technology, utilizing high voltage and high-frequency bursts of electro-surgical energy to ablate tissue. This innovative approach allows electrophysiologists to conduct safe and effective ablation procedures, ultimately enhancing patient outcomes in cardiac care.
Gala Therapeutics
Acquisition in 2022
Gala Therapeutics is a privately-held medical device company based in Menlo Park, California, that focuses on developing disease-modifying therapies aimed at improving survival and quality of life for patients with lung cancer, chronic obstructive pulmonary disease (COPD), asthma, and other pulmonary conditions. Established in 2015, the company offers innovative solutions that cater to the needs of interventional pulmonologists and thoracic surgeons. Its main product consists of a single-use catheter and an electrosurgical generator designed to deliver non-thermal energy to the airways, effectively reducing mucus-producing cells in patients. This technology enables healthcare providers to enhance treatment outcomes for their patients, addressing critical challenges in pulmonary disease management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.